Arrowhead Pharmaceuticals
ARWR
#2237
Rank
NZ$14.97 B
Marketcap
NZ$106.35
Share price
-0.98%
Change (1 day)
44.41%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): NZ-$5.70

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$5.91. In 2025 the company made an earnings per share (EPS) of NZ-$0.01775 an increase over its 2024 EPS that were of NZ-$8.88.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.7032007.19%
2025NZ-$0.01775-99.8%
2024NZ-$8.88161.39%
2023NZ-$3.4017.36%
2022NZ-$2.8919.85%
2021NZ-$2.4161.9%
2020NZ-$1.49-216.67%
2019NZ$1.28-210.77%
2018NZ-$1.1538.3%
2017NZ-$0.83-64.93%
2016NZ-$2.38-16.25%
2015NZ-$2.8428%
2014NZ-$2.22-3.85%
2013NZ-$2.31-31.58%
2012NZ-$3.37331.82%
2011NZ-$0.78-51.11%
2010NZ-$1.60-79.07%
2009NZ-$7.63-37.68%
2008NZ-$12.25-16.87%
2007NZ-$14.7438.33%
2006NZ-$10.65122.22%
2005NZ-$4.7942.11%
2004NZ-$3.37533.33%
2003NZ-$0.53-99.08%
2002NZ-$57.6425%
2001NZ-$46.1133.33%
2000NZ-$34.59-120%
1999NZ$172.93-400%
1998NZ-$57.64-81.48%
1997NZ-$311.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.51-362.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.19 139.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.77-400.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$9.82-266.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$3.25-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA